Asston Pharmaceuticals Allots 24.1 Lakh Shares Under ₹27.72 Crore Preferential Issue

Board allotted 24,10,431 preferential equity shares at Rs 115 each to 15 public investors; paid-up capital increased to Rs 10.92 Cr comprising 1,09,22,791 shares. Completes the company's first post-listing equity raise and marks a shift toward externally funded growth; allotment is concentrated among two principal investors. The issue creates shareholder dilution; this filing does not disclose the use of proceeds, investor funding rationale or deployment timeline.